Currently out of the existing stock ratings of Whitney Ijem, 40 are a BUY (74.07%), 12 are a HOLD (22.22%), 2 are a SELL (3.7%).

Whitney Ijem

Work Performance Price Targets & Ratings Chart

Analyst Whitney Ijem works at CANACCORD with a stock forecast success ratio of 30.48% fulfilled within 205.22 days on average.

Whitney Ijem’s has documented 107 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 26-Apr-2024.

Wall Street Analyst Whitney Ijem

Analyst best performing recommendations are on KRYS (KRYSTAL BIOTECH).
The best stock recommendation documented was for KRYS (KRYSTAL BIOTECH) at 6/21/2019. The price target of $48 was fulfilled within 26 days with a profit of $18.85 (64.67%) receiving and performance score of 24.87.

Average potential price target upside

SRPT Sarepta Therapeutics GBIO Generation Bio Co PASG Passage Bio RCKT Rocket Pharmaceuticals RGLS Regulus Therapeutics TNYA Tenaya Therapeutics ALNY Alnylam Pharmaceuticals BMRN Biomarin Pharmaceutical GILD Gilead Sciences KRYS Krystal Biotech RYTM Rhythm Pharmaceuticals SGMO Sangamo Therapeutics TSHA Taysha Gene Therapies  VRTX Vertex Pharmaceuticals ARCT Arcturus Therapeutics Holdings NTLA Intellia Therapeutics SGTX Sigilon Therapeutics  VERV Verve Therapeutics RARE Ultragenyx

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

175

$41.34 (30.93%)

177

3 days ago

9/16 (56.25%)

$41.34 (30.93%)

125

Hold

128

$-5.66 (-4.23%)

128

4 days ago

3/9 (33.33%)

$-2.63 (-2.01%)

61

Buy

166

$32.34 (24.20%)

166

4 days ago

8/20 (40%)

$35.37 (27.08%)

248

Buy

167

$33.34 (24.94%)

174

2 months 5 days ago

1/6 (16.67%)

$38.33 (29.79%)

39

Buy

172

$38.34 (28.68%)

113

2 months 7 days ago

1/3 (33.33%)

$44.1 (34.48%)

27

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Whitney Ijem is most bullish on?

Potential upside of $68.25 has been obtained for RARE (ULTRAGENYX)

Which stock is Whitney Ijem is most reserved on?

Potential downside of -$30.66 has been obtained for SRPT (SAREPTA THERAPEUTICS)

What Year was the first public recommendation made by Whitney Ijem?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?